For Healthcare Providers

PrinterEmail

News

Aetna's Preferred FSH Infertility Drug Coverage Changes

Recent News


Beginning January 1, 2012, Aetna will allow coverage for the following Follicle Stimulating Hormone (FSH) preferred injectable infertility drugs:

  • Bravelle (urofollitropin alfa for injection)
  • Gonal-F (recombinant follitropin alfa for injection)
  • Gonal-F RFF (recombinant follitropin alfa for injection)

In order for Aetna members to receive coverage for these drugs, physicians should prescribe one of the preferred drugs listed.  This applies to Aetna members in commercial plans.  All infertility injectable drugs require precertification.  Aetna will not provide coverage of non-preferred FSH drugs for Aetna commercial members unless they have a contraindication or intolerance to at least two of the preferred FSH drugs.